On this resident blog, PGY2 SOT resident Madhumita Rao joins us from University of Colorado Hospital to discuss the HCV-TARGET study comparing early and late initiation of HCV treatment in SOT recipients, as well as highlight concerns with use of SGLT2 inhibitors early post-kidney transplant.